Transgenic technology and the study of hepatitis viruses: A review of what we have learned

Canadian Journal of Gastroenterology

Volumn 14, Issue 9, 2000, Pages 781-787

  Milich, D R ^a  

^a Vaccine Research Institute of San Diego   (United States)

Author keywords

Hepatitis B virus; Hepatitis C virus; Hepatitis delta virus; Transgenic mice

Indexed keywords

ENVELOPE PROTEIN; HEPATITIS B CORE ANTIGEN; HEPATITIS B(E) ANTIGEN; NUCLEOCAPSID PROTEIN; STRUCTURAL PROTEIN; T LYMPHOCYTE RECEPTOR; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BIOTECHNOLOGY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HEPATITIS VIRUS; IMMUNE RESPONSE; IMMUNOMODULATION; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE; VIRUS GENE; VIRUS PATHOGENESIS; VIRUS REPLICATION;

EID: 0033660194     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2000/934202     Document Type: Review

References (58)

1. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state
2. Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice
3. Tissue preferential expression of the hepatitis B virus (HBV) surface antigen gene in two lines of HBV transgenic mice
4. Expression and replication of the hepatitis B virus genome in transgenic mice
5. Developmental regulation of hepatitis B surface antigen expression in two lines of hepatitis B virus transgenic mice
6. Hepatitis B surface antigen gene expression is regulated by sex steroids and glucocorticoids in transgenic mice
7. Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice
8. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice
9. Characterization of T cell tolerance to hepatitis B virus (HBV) antigen in transgenic mice
10. Extrathymic expression of the intracellular hepatitis B core antigen results in T cell tolerance in transgenic mice
11. Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice
12. Long term expression of the hepatitis B virus core- e- and X-proteins does not cause organ pathology in transgenic mice
13. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?
14. The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice
15. HBx gene of hepatitis B virus induces liver cancer in transgenic mice
16. High level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice
17. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice
18. Expression of the hepatitis delta virus large and small antigens in transgenic mice
19. Transgenic mouse expressing a full-length hepatitis C virus cDNA
20. Hepatitis C virus core and E2 protein expression in transgenic mice
21. Transgenic expression of hepatitis C virus structural proteins in the mouse
22. Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the Cre/lox P system
23. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice
24. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
25. Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome
26. Transgenome transcription and replication in the liver and extrahepatic tissues of a human hepatitis B virus transgenic mouse
27. High-level hepatitis B virus replication in transgenic mice
28. Viral clearance without destruction of infected cells during acute HBV infection
29. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice
30. Class I restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo
31. Mechanisms of class I restricted immunopathology: A transgenic mouse model of fulminant hepatitis
32. Immune pathogenesis of hepatocellular carcinoma
33. HBV infection, the immune response and hepatocellular carcinoma
34. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes
35. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice
36. Tumor necrosis factor-alpha negatively regulates hepatitis B virus gene expression in transgenic mice
37. Interleukin 2 and interferon alpha/beta downregulate hepatitis B virus gene expression in vivo by tumor necrosis factor dependent and independent pathways
38. Interleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a post-transcriptional mechanism
39. Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice
40. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state
41. Pathogenetic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice
42. Nondeletional T-cell receptor transgenic mice: Model for the CD4(+) T-cell repertoire in chronic hepatitis B virus infection
43. Maternofetal transmission of IgG-bound hepatitis B e antigen
44. Prevention of maternal infant hepatitis B virus transmission by immunization: The role of serum hepatitis B virus DNA
45. Autoantibody production in hepatitis B e antigen transgenic mice elicited with a self T cell peptide and inhibited with nonself peptides
46. Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice: A possible way of circumventing ″Nonresponse″ to HBsAg
47. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice
48. Characterization of self-reactive T cells that evade tolerance in hepatitis B e antigen transgenic mice
49. The serology of chronic hepatitis B infection revisited
50. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: A mechanism for persistence
51. Soluble CTLA-4 can suppress autoantibody production and elicit long term unresponsiveness in a novel transgenic model
52. Interleukin 12 suppresses autoantibody production by reversing helper T cell phenotype in hepatitis B e antigen transgenic mice
53. Production of antibody to hepatitis B surface antigen (anti-HBs) by murine hepatitis B virus carriers: Neonatal tolerance versus antigen presentation by dendritic cells
54. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice
55. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice
56. Viral cross talk: Intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver
57. Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice
58. The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice